In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in ...

The UK sets a record 22.9% payment rate under the 2025 VPAG for branded medicines, sparking criticism from the pharma industry. The ABPI warns the increase threatens industry growth and the UK’s ...

Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...

It is the only example globally of an end-to-end access pathway, where a medicine developer can work collaboratively with the ...

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending ...

The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss drugs such as semaglutide (Ozempic or Wegovy), ...

Mirror, signal THEN manoeuvre. About the author: Dr Rina Newton has 14 years industry experience in medium to big pharma working with the ABPI Code - as an originator, signatory and auditor.

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...

Novo Nordisk (NVO) has reportedly been criticized by a U.K. pharma industry group for mischaracterizing certain payments to ...

The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.

We are delighted to announce that we have updated and refreshed our training programme with new courses delivered by some new additions to our training faculty.

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...